Committee backs 340B transparency and use rules after marathon debate, with protections for rural providers
After lengthy testimony and multiple amendments, the committee voted to advance amended Senate Bill 124 (and related provisions) to the Committee of the Whole, adopting reporting and spending-use requirements for 340B net revenue and exemptions for certain small nonprofit hospitals and pharmacies.
The full story
The House Health & Human Services Committee advanced a package of measures aimed at increasing transparency and restricting uses of net revenue from the federal 340B Drug Pricing Program, adopting several sponsor amendments after extended testimony from hospitals, rural providers, pharmacies, patients and labor representatives.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in